N-Acetyl-Semax was created in 1982 by a research group from the Institute of Molecular Genetics at the Russian Academy of Sciences in Moscow. Semax is another heptapeptide nootropic that shares a comparable history, intensity and compound make-up with Noopept powder. It was first used as a treatment for cardiovascular accident (popularly known as stroke) patients suffering from brain damage but was later on found out to significantly enhance condition in healthy individuals. This nootropic invigorates the Central Nervous System and enhances memory, concentration, analytical skills, mental and physical execution. It is viewed as much more secure than different stimulants and does not bring about negative reactions like Ritalin, Adderall, or Ephedrine.
Semax is one of the various number of medications that are particularly endorsed for cognitive improvement. While it is additionally being recommended to treat various mental and psychological conditions, its impacts are aimed at enhancing the cognitive activity of the mind, and these incorporate learning skills, memory enhancement, communication skills, and logical reasoning.
Semax is a peptide with seven distinct particles. It is most dynamic in the central nervous system (CNS) where it deals with the most vital neurotransmitters in the brain, especially the most essential ones that add to the cognitive processes in the brain such as serotonin, acetylcholine, norepinephrine, and dopamine. Semax additionally empowers the glutamate receptors in the central nervous system and provides more energy to the neurons.
The strength of Semax as a nootropic is assessed to be around 1,000 times more effective than